From: Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
Variables | All | % of AR (−) | % of AR (+) | p-value |
---|---|---|---|---|
Age | Â | Â | Â | 0.02 |
 < 40 | 13 | 92 | 08 |  |
 40–60 | 72 | 67 | 33 |  |
 > 60 | 16 | 44 | 56 |  |
Tumor Grade | Â | Â | Â | 0.08 |
 1 | 7 | 29 | 71 |  |
 2 | 41 | 66 | 34 |  |
 3 | 53 | 72 | 28 |  |
T- size | Â | Â | Â | 0.57 |
 1–2 | 86 | 67 | 33 |  |
 > 2 | 15 | 60 | 40 |  |
Node status | Â | Â | Â | 0.72 |
 N0 | 50 | 68 | 32 |  |
 N+ | 51 | 65 | 35 |  |
Tumor Stage | Â | Â | Â | 0.41 |
 I | 3 | 67 | 33 |  |
 II | 76 | 70 | 30 |  |
 III | 22 | 55 | 45 |  |
Ki67 | Â | Â | Â | 0.55 |
 Low/No | 75 | 68 | 32 |  |
 High | 26 | 62 | 38 |  |
FOXA1 | Â | Â | Â | 0.03 |
 Low | 54 | 76 | 24 |  |
 High | 47 | 55 | 45 |  |
GATA3 | Â | Â | Â | 0.005 |
 Low | 74 | 74 | 26 |  |
 High | 27 | 44 | 56 |  |
Distant metastasis | Â | Â | Â | 0.004 |
 No | 64 | 77 | 23 |  |
 Yes | 37 | 49 | 51 |  |